I Learn to Live with It

At first the doctors told me that it was a branch of the F… ataxia. I was panicking and questions filled my head: will I have to be in a wheelchair? Will my condition deteriorate? How much longer will I live? Will I die? I remember all these emotions as...

Continue reading

A Dream to Accomplish

In my opinion, the pursuit of one’s dreams is a big intrinsic motivation that we all need for self-fulfillment. My quest consists in participating in the 2012 London Paralympic Games. In fact, I am a high level swimmer and for four years I have had the deepest desire of accomplishing...

Continue reading

Shoot for the moon

I hope that my testimony brings hope. My name is Emmanuelle Poirier St-Georges, I’m 25 years old and I suffer from Friedreich’s ataxia. As a child I loved sports: soccer, handball, gymnastics and ballet. I was always super competitive and I couldn’t understand why at 12 years old my performance...

Continue reading

Catena: The Results of the Negotiated Agreement

Following correspondence with Health Canada and Santhera, we present the results of the negotiated agreement: Santhera formally commits to offering, and thus delivering, Catena to Canadian patients who are approved by Health Canada’s Special Access Programme (SAP). The price will remain about the same. Santhera can in no way influence...

Continue reading

Santhera’s MICONOS Trial with Catena in Friedreich’s Ataxia Misses Primary Endpoint

Press Release Liestal, Switzerland, May 20, 2010 – Santhera Pharmaceuticals (SIX: SANN) announced today that its MICONOS Phase III study evaluating Catena®/Sovrima® for the treatment of Friedreich’s Ataxia missed its primary endpoint. Trends towards improvement in the key neurological endpoint were however identified by a meta-analysis of all Santhera’s Phase...

Continue reading

Additional documents on Catena (Idebenon)

Some relevant information about Catena® (Idebenon) Catena®: Fact Sheet Catena®(idebenone): Product Monograph Catena®(idebenone): Product Monograph. Part III Actual Payer Coverage in Canada for CATENA® (Idebenon) Santhera Pharmaceuticals about preliminary results of the CATENA US clinical trial

Continue reading